Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aromatase Inhibitor-Associated Musculoskeletal Symptoms (AIMSS)”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Not applicableStudy completedNCT07500038
What this trial is testing

Evidence-Based Practice for the Management of Musculoskeletal Symptoms in Breast Cancer Patients Undergoing Endocrine Therapy: A Multicultural Perspective

Who this might be right for
Breast NeoplasmsAromatase Inhibitor-Associated Musculoskeletal Symptoms (AIMSS)
Yuling CAO 289
Testing effectiveness (Phase 2)Study completedNCT01194440
What this trial is testing

Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms

Who this might be right for
Ductal Carcinoma in SituEstrogen Receptor-positive Breast CancerProgesterone Receptor-positive Breast Cancer+5 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 63
Not applicableLooking for participantsNCT06831838
What this trial is testing

Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors

Who this might be right for
Breast Cancer
Mayo Clinic 115
Testing effectiveness (Phase 2)Looking for participantsNCT07443943
What this trial is testing

A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8+2 more
University of Michigan Rogel Cancer Center 20
Not applicableStudy completedNCT06106282
What this trial is testing

Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8+2 more
Mayo Clinic 105
Not applicableStudy completedNCT06228768
What this trial is testing

Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer

Who this might be right for
PostmenopausalBreast Cancer
University of Michigan Rogel Cancer Center 50
Very early researchLooking for participantsNCT06123286
What this trial is testing

Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms

Who this might be right for
Breast CancerAromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)Joint Pain
Philip Chang 30
Not applicableWithdrawnNCT04205786
What this trial is testing

Vitamin B12 for Aromatase Inhibitors Associated Musculoskeletal Symptoms in Breast Cancer

Who this might be right for
HR-positive Breast Cancer
Case Comprehensive Cancer Center